Top pharmacist urges more GLP-1s to be given to people
She will discuss the subject in more depth along with other key opinion leaders as part of the DPC Summer Form, which was created to disseminate the findings from this year’s ADA's Virtual 80th Scientific Sessions.
Dr David Strain, Dr Patrick Holmes, Dr Marc Evans and Nurse Consultant Debbie Hicks will join Victoria in the online session entitled GLP-1 ADA Round up on Wednesday, July 8 from 7pm.
Victoria said: “GLP-1s can help people who struggle to control their blood glucose levels with positive benefits such as weight loss.
“Usually my role as a pharmacist is to offer an opinion on things like where these drugs would fit in with current treatment pathways.
“GLP-1s are under used at the moment because when NICE originally reviewed them they put a strict set of criteria against them and made them third line therapy. We now have much more high-quality evidence for their benefits and we need to balance this with the potential cost and current confusion as to how we can use them. The tide is turning, but it’s still a fight.”
AstraZeneca provided an arms-length grant for the meetings.